Home
About
Overview
Sharing Data
ORCID
Help
History (6)
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer.
Biomarkers, Pharmacological
Blood-Aqueous Barrier
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
Chronic myeloid leukemia manifested as myeloid sarcoma: Review of literature and case report.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Chronic myeloid leukemia manifested as myeloid sarcoma: Review of literature and case report.
Chronic myeloid leukemia manifested as myeloid sarcoma: Review of literature and case report. J Clin Neurosci. 2019 Jun; 64:269-276.
View in:
PubMed
subject areas
Brain Neoplasms
Female
Frontal Lobe
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Magnetic Resonance Imaging
Middle Aged
Neoplasms, Second Primary
Sarcoma, Myeloid
authors with profiles
Helen H Shi
Lance M Villeneuve
Teresa Ann Scordino